Media 280723

CTO Mr Craig Weller said on Aqua Phase studies revealing the absorption of CBD as more than 4 times greater than CBD in oil:
Bod has been sweating on the PK study for months. It needed to show improved bioavailability of 30% for the deal to proceed, it exceeded by a factor of 10, what this means is that if we ingest 100mg of CBD in oil, we will normally absorb 6-8% of the dose. With Aqua Phase, the CBD absorption is 32% This means we can either get a better response to the CBD or otherwise we can reduce the Aqua Phase dose – giving potentially less side effects and providing CBD raw material savings.
Australia's top 20 cannabis companies
26 May 2022
Published by: Business News Australia
Bod prepares to launch pharma-grade CBG product in Oz and UK
26 May 2022
Published by: Cannabiz
Bod Australia (ASX:BOD) completes successful study on new medicinal cannabis product
25 May 2022
Published by: The Market Herald
ASX Health Stocks: Vectus jumps 13pc on promising Phase 1 study results
25 May 2022
Published by: Stockhead
BOD Australia says CBG cannabis product useful in range of common disorders
25 May 2022
Published by: Market Index
Weed Week: Woody Harrelson opens weed dispensary and Byron Bay could be home to a cannabis resort
20 May 2022
Published by: Stockhead
New trade body launches with vision ‘to embed emerging therapies as part of Australia’s healthcare landscape’
12 May 2022
Published by: Cannabiz
Bod signs up first patients for over-the-counter insomnia trial
10 May 2022
Published by: Cannabiz